Long-term results of preoperative hypofractionated chemoradiotherapy for high-risk HER2-positive and triple-negative breast cancer subtypes

Raquel Ciérvide, Ángel Montero, Mariola García-Aranda, Jeannette Valero, Beatriz Álvarez, Xin Chen, Rosa Alonso, Mercedes López, Ovidio Hernando, Emilio Sánchez, Carmen Rubio

Open source

DOI
10.1007/s12094-026-04527-x
Published
2026-08-08
Container
Clinical and Translational Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12094-026-04527-x,
  title = {Long-term results of preoperative hypofractionated chemoradiotherapy for high-risk HER2-positive and triple-negative breast cancer subtypes},
  author = {Raquel Ciérvide and Ángel Montero and Mariola García-Aranda and Jeannette Valero and Beatriz Álvarez and Xin Chen and Rosa Alonso and Mercedes López and Ovidio Hernando and Emilio Sánchez and Carmen Rubio},
  year = {2026},
  journal = {Clinical and Translational Oncology},
  doi = {10.1007/s12094-026-04527-x},
  url = {https://doi.org/10.1007/s12094-026-04527-x}
}

RIS

TY  - JOUR
TI  - Long-term results of preoperative hypofractionated chemoradiotherapy for high-risk HER2-positive and triple-negative breast cancer subtypes
AU  - Raquel Ciérvide
AU  - Ángel Montero
AU  - Mariola García-Aranda
AU  - Jeannette Valero
AU  - Beatriz Álvarez
AU  - Xin Chen
AU  - Rosa Alonso
AU  - Mercedes López
AU  - Ovidio Hernando
AU  - Emilio Sánchez
AU  - Carmen Rubio
PY  - 2026
JO  - Clinical and Translational Oncology
DO  - 10.1007/s12094-026-04527-x
UR  - https://doi.org/10.1007/s12094-026-04527-x
ER  - 

APA

Ciérvide, R., Montero, Á., García-Aranda, M., Valero, J., Álvarez, B., Chen, X., Alonso, R., López, M., Hernando, O., Sánchez, E., & Rubio, C. (2026). Long-term results of preoperative hypofractionated chemoradiotherapy for high-risk HER2-positive and triple-negative breast cancer subtypes. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04527-x

Source records